Exploring phage diversity and potential: Development of phage therapy for bacterial infection by Wirjon, Ira Aryani & Arip, Yahya Mat
Proceedings of The 2nd Annual International Conference Syiah Kuala University 2012  
& The 8th IMT-GT Uninet Biosciences Conference 
Banda Aceh, 22-24 November 2012 
 
286 
Volume 2 Number 1, 2012 
 
Exploring phage diversity and potential: Development of 
phage therapy for bacterial infection 
 
Ira Aryani Wirjon & Yahya Mat Arip*  
 
School of Biological Sciences, Universiti Sains Malaysia 11 800 Penang, Malaysia                                                                                    
Corresponding author: ymarip@usm.my 
 
Abstract.The recent increase in drug-resistance bacteria has become a very serious threat to the treatment of infectious 
diseases. Over recent decades, a growing numbers of literatures have validated the application of bacteriophages for 
therapy against antibiotic-resistance bacteria. With rapid dissemination of these resistant bacteria pathogens, the 
interest in alternative remedies to antibiotics using bacteriophages therapy is gaining new ground. Based on the recent 
studies of bacteriophage applications against bacterial infections in countries where this alternative therapy has been 
approved, many scientists and companies believed that phages have the ability to treat and prevent diseases caused by 
bacteria. Malaysia, being well known as one of the megadiverse countries could promise the potential new phages that 
could be applied in phage therapy. The overall objectives of this research including isolation and purification of 
potentially new phages from environments, characterization of the isolated phages based on morphological study, 
physicochemical attributes, genomic and proteomic analysis. Lastly, the isolated phages would be developed into phage 
therapy against bacterial infection through in vitro and in vivo test. Preliminary results presented here, show a total of 
four phages were successfully isolated from human waste. Two of the phages were successfully isolated infecting Proteus 
mirabilis that caused urinary tract infection in human whereas another two phages infecting Escherichia coli 0157:H7 
(caused food-borne diseases) and Escherichia coli ATCC 13706, respectively. 
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Introduction 
Bacterial viruses or bacteriophages (phages for short) are viruses that could infect and 
destroy bacteria. They have been referred to as bacterial parasites and occupy all habitats of the 
world where bacteria thrive. It has been estimated that there are ten phage particles for each 
bacterial cell (Skurnik and Strauch, 2006). Phages are among the most common biological 
entities on the earth and widely distributed entity in the biosphere with an estimated viral 
population of greater than 1031 particles (McAuliffe et. al., 2007). Some phages are highly 
specific to their host while others are extremely broad in their host range (Skurnik and Strauch, 
2006).  
Phages, of which there are two orders with ten families infecting eubacteria and four 
families infecting archaebacteria as registered in the International Committee on Taxonomy of 
Viruses (ICTV). About 5360 phages are tailed phages and 1790 phages are reported belonged to 
cubic or filamentous or pleomorphic phages with at least 100 novel phages are described every 
year (Ackermann, 2011). This phage biology still does not include five pending families of 
phages that could infect archaebacteria. Phage predation kills estimated one-half of the bacterial 
population worldwide every 48 hours. Phage played a critical role for the evolution of the 
bacterial biosphere, in part by accelerating the mutation rates of bacteria. Phages which 
mutating at a more rapid rate than their prey, of course, finds means to overcome this resistant 
bacteria. The billions of years of this evolution originating from predator-prey relationship has 
made phages a potentially rich resource for the discovery of new antibacterial agents as a 
complement for the existing treatments (Deresinski, 2009).  
Phage therapy serves as a potential candidate to fight pathogenic bacteria along side with 
the current treatments available. Phage therapy involves using phages or their products as 
bioagents for the treatment or as prophylaxis of infectious diseases caused by the bacteria 
(Matsuzaki et. al., 2005). Phages have been proposed as active natural antimicrobial agents 
against bacterial infections in human, veterinary science, environment and agricultural 
importance. The using of phages has also been discussed as hygiene measures in food 
production facilities as well as hospitals. 
 
Materials and Methods 
Bacterial strains and culture media 
A total of three bacterial strains, namely Proteus mirabilis, Escherichia coli 0157:H7 and 
Escherichia coli ATCC 13706 were used as primary host for the isolation, propagation, 
characterization and development of the bacteriophage. All the bacterial stock cultures were 
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stored at -80˚C in 40% (v/v) glycerol. When needed, frozen cultures were cultivated in Luria 
Bertani (LB) broth and plated onto LB agar. The bacteria and isolated bacteriophages were 
propagated in LB broth and agar. For plaque assays, the top agar was prepared with LB broth 
supplemented with 0.5% bacteriological agar. 
Isolation and screening of bacteriophages 
Bacteriophages were isolated from human waste. The sample was taken freshly using 
sterile container and used immediately for isolation. A single colony of the host was cultured in 5 
ml of LB broth and incubated in shaker with agitation speed of 180 rpm at 37˚C. After 2-5 
hours, about 5 ml of the sample was added into the cultured host with the addition of 10 ml of 
double-strength LB broth and the mixture was incubated again at the same condition for 
overnight. On the next day, the culture was harvested at 10 000 rpm for 15 minutes using cold 
centrifugation (4˚C) before the supernatant was filter sterilized using 0.2  membrane filter.  
 The filtrate was then further used for phage screening by performing plaque assay using 
overlay agar technique (0.5% LB top agar). Ten-fold serial dilutions of filtrate were prepared 
from 10-2 until 10-10 in LB broth. For the original filtrate stock, 100 µl of fresh (2-5 hours 
incubation) cultured host and 100 µl of filtrate were added on ½ LB agar and the mixture was 
overlaid with 3 ml of top agar. The plate was moved clockwise and anticlockwise for several 
times to ensure complete and proper mixing. Similarly, all the prepared dilutions were 
performed the same steps. For control, the filtrate was replaced with 100 µl of LB broth. All the 
plates were inverted and incubated overnight at 37˚C. The morphology of phage plaques were 
observed and recorded. 
Purification and enrichment of bacteriophages 
100 µl of fresh bacterial culture (2-5 hours incubation at 37˚C, 180 rpm) that acts as a 
host for the isolated bacteriophage was added on ½ LB agar and overlaid with 3 ml of top agar 
(0.5% of melted LB agar). The top agar was mixed properly with the bacterial culture and let to 
be hardened. After the top agar was hardened, a well isolated plaque obtained from previous 
screening process plate was purified using sterile toothpick by poking the centre of the plaque 
and pricked onto the hardened agar (new bacterial lawn). This purification step was repeated for 
three times. As final step, the plaques-containing top agar was scrapped and eluted in SM buffer 
(50mM of Tris-HCl, 100 mM of NaCl, 10 mM of MgCl2.6H2O) for overnight at 4˚C. Then, the 
isolated phage-containing SM buffer was centrifuged at 10 000 rpm for 15 minutes. The 
supernatant was filter sterilized using 0.2  membrane filter and the phage stock was stored at 
4˚C.  
The enrichment of the phage stock was further performed exactly as isolation step with 
the addition of 5% of chloroform as the final step. Plaque assay was repeated once again for the 
purified phage for the determination of phage titre before the characterization steps were carried 
out. The plaques were observed and recorded. 
Bacteriophages visualization 
The enrichment of bacteriophages was carried out to obtain the titre approximately 1010 pfu/ml. 
The sample containing the high titre was spotted onto a film-coated carbon grid and negatively 
stained with 2% methylamine tungstate, pH 6.5 before the bacteriophage morphology could be 
observed using transmission electron microscope (Philips CM12 equipped with analysis system, 
Philips Electron Optics). 
 
Results and Discussion 
A total of four phages were successfully isolated from human waste. All of the isolated 
phages produced different plaques in term of size, shape and turbidity when plaque assays were 
performed. As shown in the Figure 1 (a), the plaque was round-shaped, clear and large with 
mean diameter of the plaque 29.5 mm. Both Figure 1 (b) and (c) also produced round-shaped 
and clear plaque with very small size of the plaques (mean diameter of 1.0 mm and 1.5 mm, 
respectively). Instead of clear, Figure 1 (d) showed a clear ring surrounding the turbid plaques 
and had similar shape like others with mean diameter of 2.0 mm. 
Morphological characterization of phages using TEM, one of the most used methods for 
phages classification. All the isolated phages were tailed phages that constitute the order 
Caudovirales and fell into three families, characterized by contractile, long and noncontractile, or 
short tails and named respectively Myoviridae, Siphoviridae and Podoviridae (Ackermann, 2011). 
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Based on the electron micrograph shown in the Figure 2 (a) and (b), both the isolated 
phages could be assigned to the family Siphoviridae. This morphology was similar to PW2 phage 
that possessed icosahedral head and a long, non contractile tail (Phumkhachorn and 
Rattanachaikunsopon, 2010). As can be seen in the Figure 2 (c), the isolated phage could be 
assigned to the family Podoviridae. Similarly, phage ⱷIBB-PF7A was reported morphologically 
belongs to the family Podoviridae since it has a very short non-contractile tail (Sillankorva et. 
al., 2008). The isolated phage in the Figure 2 (d) could be assigned to family Myoviridae as 
reported for phage ϕKZ which also had very long contractile tail that fell into the same family 
(Krylov et. al., 2003).  
The isolated phages as shown in the Figure 2 (a) and (b) had a mean diameter of 66 nm 
and 61 nm, a tail length of 208 nm and 177 nm as well as a tail diameter of 15 nm and 11 nm, 
respectively. Instead of long tail, as can be seen in the Figure (c), the isolated phage had mean 
diameter of 109 nm, tail length of 89 nm and tail diameter of 28 nm. Meanwhile, the isolated 
phage as shown in the Figure 2 (d) had mean diameter of 57 nm, tail length of 120 nm and tail 
diameter of 22 nm. Similarly, all the isolated phages had isometric heads. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. (a) and (b) Phages infecting Proteus mirabilis (c) Phage infecting E.coli 0157:H7;  
(d) Phage infecting E.coli ATCC 13706. Morphology of the plaques on the plates using  
overlay agar  Technique  (0.5% top agar). 
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Figure 2. (a) and (b) Phages infecting Proteus mirabilis; (c) Phage infecting E.coli 0157:H7; (d) Phage 
infecting E.coli ATCC 13706. Negative stained electron micrograph of phages with 2% methylamine 
tungstate. 
Conclusions 
For the preliminary results, about four phages were successfully isolated from human 
waste. All the isolated phages were distinct and fell into the order of Caudovirales (tailed 
phages) with possible three families of Siphoviridae, Podoviridae and Myoviridae. Further 
characterization work are in progress before the isolated phage could be developed as phage 
therapy against infectious diseases that caused by pathogenic bacteria. 
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